DENTSPLY INTERNATIONALInsider Trading & SEC Form 4 Analysis
Institutional analysis of internal capital flows based on SEC Form 4 filings.
Automated_Intelligence_Report :: XRAY
Algorithmic analysis of recent insider trading activity for XRAY reveals a bullish posture among the C-suite and board members. Based on the latest SEC Form 4 filings, we have tracked capital events executed by 19 distinct corporate insiders. The aggregate nominal exposure during this reporting cycle reached $2.96M.
Market dynamics show a positive net capital flow of $0.21M when isolating open-market purchases versus open-market sales. The trading volume is heavily weighted towards open-market executions, providing a clearer signal of insider conviction regarding current valuation levels compared to option-based equity grants.
From a microstructural perspective, the landscape is fragmented. LUCIER GREGORY T led the buying pressure, while LUCIER GREGORY T registered the largest single offload of shares. Continuous monitoring of these Tier-1 actors is essential, as their liquidity decisions often precede material corporate events or reflect an informed, asymmetric perspective on the future performance of XRAY.
$2.96M
USD NOMINAL VALUE19
UNIQUE C-SUITE ENTITIES2026.05.22
ISO_8601 FORMATAutomated_Queries :: Frequently Asked Questions
>Who is currently buying XRAY stock?
Based on the latest SEC Form 4 filings, LUCIER GREGORY T (Director) has been actively acquiring shares. The total recent insider buying volume stands at $1.12M.
>Are XRAY insiders selling their shares?
Yes, we have tracked $0.92M in recent insider liquidations. The most notable recent seller is LUCIER GREGORY T, who executed the largest single offload.
>What is the overall insider sentiment for XRAY?
The short-term structural capital flow indicates a BULLISH sentiment, with a net flow of $0.21M generated by 19 active C-Suite entities.